KLK3 and prostate carcinoma: Among the tested variables, PSA level demonstrated the highest discriminative power, with an AUC of 0.782 (95% CI: ~0.70–0.86), suggesting a strong ability to differentiate between patients with and without clinically significant prostate cancer.